Alkermes PLC (NAS:ALKS)
$ 24.46 0.33 (1.37%) Market Cap: 4.14 Bil Enterprise Value: 3.76 Bil PE Ratio: 9.67 PB Ratio: 3.30 GF Score: 70/100

Alkermes Plc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 03:00PM GMT
Release Date Price: $20.28 (-1.22%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

Good morning, everyone, from the Virtual JPMorgan Healthcare Conference. My name is Cory Kasimov, and it's my pleasure to introduce our next company, Alkermes, and Chairman and CEO, Richard Pops. Please note that following this presentation, we will have a Q&A session where you have the ability to submit questions via the conference portal.

So with that, Rich, thanks for being here, and let me turn things over to you.

Richard F. Pops
Alkermes plc - Chairman & CEO

Thank you, Cory. Good morning, and good to see you. And hello to everybody on the virtual presentation. So this year's strategy, and therefore, this presentation, is focused on revealing and elaborating the value that's headed in this distinctive company. In 2020, we demonstrated the resiliency of our people and our business, and we added new scientific, financial and governance elements to the story. So 2021 is about focusing on translating all of this into a growing valuation. So on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot